Epilepsy Therapeutics Market - Global Industry Perspective Comprehensive Analysis and Forecast, 2015 to 2021

Report Code: ZMR-91 | Report Format : | Status : Upcoming |

Abstract

Epilepsy is a chronic neurological disorder characterized by unpredictable seizures. Epilepsy is the fourth most common neurological disorder that affects peoples of all age group. Seizures may be classified as focal seizures, generalized seizures, and other seizures. Focal seizures are the most common type of epilepsy which involves secondary generalized tonic/clonic seizures (sGTCS) and complex partial seizures. Generalized seizures include myoclonic seizures, tonic seizures, atonic seizures, absences, and clonic seizures. These seizures occur when neurons in the brain or a group of nerve cells send wrong signals to the body.

Treatment of epilepsies is done by using antiepileptic drugs (AEDs). Antiepileptic drugs are segmented into two major categories namely first generation AEDs and second generation AEDs. Selection of drugs is done by prescriber depending upon the type of seizure, part of brain involved in epilepsy, age of patient.

Epilepsy therapeutic drug market is mostly driven by increasing prevalence of neurological disorders and technological advancements across many countries. Moreover, increasing awareness about diagnostics and treatment of neurological disorders in global market also help in driving the epileptic market growth. Non availability of medical facilities in poor and developing countries can restrict or hinder the growth of epileptic therapeutic market over the years. Conversely, the prescribing pattern of drugs that give preference to first generation AEDs over second generation AEDs is restraining the epilepsy therapeutics market. Nonetheless, ongoing research and development in the healthcare literacy rate are expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the epileptic therapeutic market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the epileptic therapeutic drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein type segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the epileptic therapeutic drug market based on type and regional segment.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America & Europe were the leading regional segments of the epileptic therapeutic drug market due to availability of second generation antiepileptic drug.

Three new AEDs have been approved in the U.S. since 2012 including ezogabine/retigabine, perampanel and eslicarbazepine acetate. Ezogabine/retigabine and perampanel among these have new mechanism of action and thus it is capturing good amount of market share in the U.S. The epileptic therapeutic market is expected to witness the highest growth in the Asia-Pacific region in the coming years due to high prevalence of epilepsy in India and China, increasing health care infrastructure, incomes and awareness.

Key players in epileptic therapeutic market include Abbott Laboratories, GlaxoSmithKline plc, Cephalon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis AG, Sunovion Pharmaceuticals, Inc.., Valeant Pharmaceuticals International, Inc., Sanofi S.A. and Shire.

This report segments the epileptic therapeutic market are:-

Epilepsy Therapeutics Market: Type Segment Analysis

  • First Generation
  • Second Generation

Epilepsy Therapeutics Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle east & Africa

Related Reports

Upper Respiratory Tract Treatment Infection Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1720 | Report Format:

Global Upper Respiratory Tract Treatment Infection Market: Overview One of the most common reasons for the people visiting the clinics and hospitals is upper respiratory tract infection. A contagious and acute infection that occurs in the upper respiratory tract is known as upper respiratory tra...Read More

Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1712 | Report Format:

Global Sickle Cell Anemia Treatment Market: Overview A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal cond...Read More

Tuberculosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1702 | Report Format:

Global Tuberculosis Therapeutics Market: Overview Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the...Read More

Systemic Infection Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1701 | Report Format:

Global Systemic Infection Treatment Market: Overview Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the persons bloodstream and gradually spreads to the whole body. The syst...Read More

Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1694 | Report Format:

Global Empty Capsules Market: Overview Empty capsules allow users to fill colorants, bulking agents, and fillers on their own in the capsule. It also permits the user to mix different ingredients together and accordingly decide the specifications of the capsules. Empty capsules are safe, cheaper...Read More

Choose License Type: